Total amount: € 0,00
Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,014
Online ISSN 1827-1820
Wollina U., Goldman A., Heinig B.
1 Department of Dermatology and Allergology, Academic Teaching Hospital of the Technical, University of Dresden, Dresden, Germany;
2 Clinica Goldman of Plastic Surgery, Porto Alegre, RS, Brazil;
3 Centre for Physical Therapy and Rehabilitation, Hospital Dresden-Friedrichstadt, Academic Teaching Hospital of the Technical, University of Dresden, Dresden, Germany
AIM: We evaluated the outcome and risks of tumescence liposuction in patients with advanced lipedema or Dercum’s disease.
METHODS: Six patients treated at a single center during the years 2004 to 2008 have been included. All patients were female and obese (body mass index 34 to 41.9; mean 38.2±3.8) with an age range from 29 to 78 years (mean 55.7±20.5 years), five of them had co-morbidities.
RESULTS: The total amount of lipoaspirates varied between 1 500 mL and 4 800 mL. Pain could be reduced in all four patients with Dercum’s disease. Large adipose tissue removing implies a better the outcome for pain. Patient’s satisfaction was “high” or “very high” in 5 and “medium” in one. The most common adverse effect was met-hemoglobulinemia (N.=4).
CONCLUSION: Tumescence liposuction is a treatment option for lipedema and Dercum’s disease. With careful monitoring the procedure is safe even for patients in advanced stages, higher age and with co-morbidities.